524636 Stock Overview
Oxygenta Pharmaceutical Limited manufactures and sells bulk drugs and active pharmaceutical ingredients in India.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Oxygenta Pharmaceutical Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹37.86 |
52 Week High | ₹52.27 |
52 Week Low | ₹25.02 |
Beta | 0.21 |
1 Month Change | 30.73% |
3 Month Change | 14.21% |
1 Year Change | 20.69% |
3 Year Change | n/a |
5 Year Change | 323.96% |
Change since IPO | 1,702.86% |
Recent News & Updates
Recent updates
Shareholder Returns
524636 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -6.1% | -0.1% | 1.8% |
1Y | 20.7% | 55.9% | 46.4% |
Price Volatility
524636 volatility | |
---|---|
524636 Average Weekly Movement | 11.7% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Volatility Over Time: 524636's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1990 | 157 | Sai Vankineni | www.oxygentapharma.com |
Oxygenta Pharmaceutical Limited manufactures and sells bulk drugs and active pharmaceutical ingredients in India. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022.
Oxygenta Pharmaceutical Limited Fundamentals Summary
524636 fundamental statistics | |
---|---|
Market cap | ₹1.27b |
Earnings (TTM) | -₹153.65m |
Revenue (TTM) | ₹372.88m |
3.4x
P/S Ratio-8.3x
P/E RatioIs 524636 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
524636 income statement (TTM) | |
---|---|
Revenue | ₹372.88m |
Cost of Revenue | ₹446.13m |
Gross Profit | -₹73.24m |
Other Expenses | ₹80.41m |
Earnings | -₹153.65m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -4.59 |
Gross Margin | -19.64% |
Net Profit Margin | -41.21% |
Debt/Equity Ratio | -222.6% |
How did 524636 perform over the long term?
See historical performance and comparison